Li Yi-Ze, Wen Lei, Wei Xu, Wang Qian-Rong, Xu Long-Wen, Zhang Hong-Mei, Liu Wen-Chao
Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
The Cadet Brigade, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Oncol Rep. 2016 Sep;36(3):1569-75. doi: 10.3892/or.2016.4912. Epub 2016 Jul 5.
Recent lentiviral-based microRNA (miRNA) library screening has identified miRNA-7 (miR-7) as an anti‑angiogenic miRNA in human umbilical vein endothelial cells (HUVECs). However, the underlying mechanism of miR-7 in the suppression of angiogenesis remains largely unknown. In the present study, we report that miR-7 inhibition promoted angiogenesis by upregulating vascular endothelial growth factor (VEGF) and directly targeting Krüppel-like factor 4 (KLF4). Downregulation of miR-7 promoted tube formation of HUVECs, accompanied by upregulation of mRNA and protein levels of both VEGF and KLF4. miR-7 directly targeted KLF4 as demonstrated by luciferase reporter assay and miR-7 mimics decreased KLF4. Furthermore, bioinformatic analysis revealed the presence of multiple DNA-binding elements of KLF4 in the VEGF promoter. Chromatin immunoprecipitation (ChIP) demonstrated that the KLF4 antibody specifically pulled down the VEGF promoter in the HUVECs. Furthermore, ectopic overexpression of KLF4 induced VEGF mRNA and protein levels. In addition, KLF4 silencing inhibited the angiogenesis induced by the miR-7 inhibitor in the HUVECs. Our results demonstrated that KLF4 is a direct target of miR-7 and a transcription activator of VEGF. These findings indicate that the miR-7-KLF4-VEGF signaling axis plays an important role in the regulation of angiogenesis in HUVECs, suggesting that miR-7 is a potential agent for the development of anti-angiogenic therapeutics in vascular diseases and solid tumors.
最近基于慢病毒的微小RNA(miRNA)文库筛选已将miRNA-7(miR-7)鉴定为人脐静脉内皮细胞(HUVECs)中的一种抗血管生成miRNA。然而,miR-7抑制血管生成的潜在机制仍 largely未知。在本研究中,我们报告miR-7抑制通过上调血管内皮生长因子(VEGF)并直接靶向Krüppel样因子4(KLF4)促进血管生成。miR-7的下调促进了HUVECs的管形成,同时伴随着VEGF和KLF4的mRNA和蛋白水平的上调。荧光素酶报告基因检测表明miR-7直接靶向KLF4,并且miR-7模拟物降低了KLF4。此外,生物信息学分析揭示了VEGF启动子中存在多个KLF4的DNA结合元件。染色质免疫沉淀(ChIP)表明KLF4抗体特异性地沉淀了HUVECs中的VEGF启动子。此外,KLF4的异位过表达诱导了VEGF的mRNA和蛋白水平。此外,KLF4沉默抑制了HUVECs中miR-7抑制剂诱导的血管生成。我们的结果表明KLF4是miR-7的直接靶标和VEGF的转录激活剂。这些发现表明miR-7-KLF4-VEGF信号轴在HUVECs血管生成的调节中起重要作用,提示miR-7是血管疾病和实体瘤中抗血管生成治疗药物开发的潜在药物。